DREAMS Program for Pediatric Stem Cell Transplant Patients
This study is testing a program called DREAMS (Developing Restful Environments and Management Strategies) to help children aged 9-17 who are receiving a stem cell transplant at Boston Children's Hospital. The DREAMS program includes a video about sleep experiences during transplant and a "Sleep and Circadian Care Kit." This kit contains items like earplugs, a white noise machine, an eye mask, and a lightbox, all designed to help improve sleep and daily rhythms (circadian health) during their hospital stay. To join, you must be an English-speaking child aged 9-17 scheduled for a stem cell transplant at Boston Children's Hospital, with a primary caregiver who also speaks English. The study will look at how many eligible patients join, how well they accept the program, and how often they use the items in the DREAMS Care Kit. The current recruitment status is unclear.
- Study design
- This is a single-arm pilot study, meaning all 10 participants will receive the DREAMS program. The study does not specify a phase.
- What's involved
- Participants will watch an introductory video and receive a Sleep and Circadian Care Kit. Usage of the kit will be measured at a follow-up assessment visit between Day 21 and Day 28 after transplant.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed up at an assessment visit between Day 21 and Day 28 after their stem cell transplant.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Eric Zhou, PhD · PRINCIPAL_INVESTIGATOR · Dana-Farber Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Enrollment RateScreening (Day -30 to -1)
Defined as the proportion of eligible participants approached by research staff and consent to participate in the study with the cutoff set at ≥30% of eligible participants that are approached and agree to participate.
- Acceptability of Intervention Measure Scale ScoreAt Follow-up Assessment Visit (Day 21, up to Day 28)
Participants reporting an average score of ≥4 ("Agree") on the Acceptability of Intervention Measure scale, a four-item questionnaire assessing the acceptability of an intervention, on a 5-point scale with options ranging from Completely Agree to Completely Disagree.
- DREAMS Care Kit Usage RateAt Follow-up Assessment Visit (Day 21, up to Day 28)
Feasibility of the DREAMS Program intervention is defined as ≥50% of participants reporting usage of at least one of the Care Kit materials.
- Intervention Assessment Completion RateAt Follow-up Assessment Visit (Day 21, up to Day 28)
Feasibility of the DREAMS Program intervention is defined as ≥80% of enrolled participants completing the Follow-up Assessment.